Residency · Residency · Family Medicine

Low Back Pain: Advanced Management and Chronic Pain Transition

Overview

Low back pain (LBP) is the leading cause of disability worldwide and one of the most common reasons for primary care visits. While most acute LBP resolves within 4 to 6 weeks, a significant proportion transitions to chronic pain. This seminar focuses on advanced management, preventing chronicity, interventional options, and the biopsychosocial framework essential for managing persistent LBP.

Definitions

Acute LBP is defined as pain lasting less than 4 weeks. Subacute LBP spans 4 to 12 weeks. Chronic LBP is pain persisting beyond 12 weeks or beyond the expected tissue healing time. Radiculopathy refers to nerve root irritation causing pain, weakness, or sensory changes in a dermatomal distribution. Neurogenic claudication is bilateral leg pain or weakness with standing and walking that is relieved by sitting or flexion, characteristic of lumbar spinal stenosis.

When to Image

Indications for Imaging

Imaging is indicated when red flags are present, including cancer history, unexplained weight loss, IV drug use, immunosuppression, prolonged steroid use, trauma, progressive neurological deficits, and cauda equina symptoms. Additional indications include severe or progressive neurological deficits, symptoms not improving after 6 weeks of conservative treatment, suspected fracture in elderly patients after minor trauma or with osteoporosis risk factors, and pre-surgical planning.

Imaging Selection

X-ray is the first-line study for suspected fracture, spondylolisthesis, or deformity assessment. MRI without contrast is the gold standard for disc herniation, spinal stenosis, nerve root compression, infection, and tumor, and is preferred over CT for soft tissue evaluation. MRI with contrast is appropriate when infection, post-surgical evaluation, or tumor is suspected. CT is used when MRI is contraindicated and provides better bony detail. It is critically important to recognize that imaging findings often do not correlate with symptoms: disc bulges are present in 50% of asymptomatic 40-year-olds, and attributing pain to incidental findings should be avoided.

Identifying Psychosocial Yellow Flags

Yellow flags predict chronicity and disability more reliably than imaging findings. These include the belief that pain is harmful and activity should be avoided (fear-avoidance), catastrophizing (an exaggerated negative mental set about pain), depression, anxiety, and stress, social withdrawal and isolation, an expectation of passive treatment rather than active participation, job dissatisfaction, workplace conflict, or compensation claims, and prolonged rest with activity avoidance. Early identification and addressing of these factors reduces chronic pain development. Useful screening tools include the STarT Back Screening Tool, which stratifies patients into low, medium, and high risk for chronicity, and the Orebro Musculoskeletal Pain Questionnaire.

Preventing the Acute-to-Chronic Transition

Key Strategies

Reassurance and education are fundamental: most LBP is benign and self-limited, and spinal structures are strong. Early return to normal activity and work (with modified duties if needed) should be encouraged. Bed rest offers no benefit beyond 1 to 2 days and should be avoided. Unnecessary imaging can lead to anxiety, unnecessary interventions, and worse outcomes. Psychosocial factors should be addressed early. Activity progression should be time-contingent rather than pain-contingent. Opioids should be avoided for acute LBP if possible, and if used, should be limited to less than 7 days. Early physical therapy referral is appropriate for patients at medium to high risk of chronicity, following the STarT Back approach.

Conservative Management

Physical Therapy (First-Line)

Physical therapy is first-line and should include individualized exercise programs incorporating core stabilization, McKenzie method, and motor control exercises. Graded activity and graded exposure are particularly valuable for fear-avoidant patients. Manual therapy, including spinal manipulation for acute LBP and mobilization, has the most evidence for short-term relief. Among modalities, heat may provide short-term relief, but evidence is limited for ultrasound, TENS, and traction.

Non-Pharmacologic Therapies

Cognitive behavioral therapy (CBT) has the strongest evidence for chronic LBP and addresses catastrophizing, fear-avoidance, and maladaptive coping. Mindfulness-based stress reduction (MBSR) has moderate evidence for chronic LBP. Yoga and tai chi have moderate evidence and improve both function and pain. Acupuncture provides moderate short-term benefit for chronic LBP. Massage therapy offers short-term relief. Multidisciplinary pain rehabilitation programs, which combine physical therapy, psychology, occupational therapy, and medical management, are the most effective approach for chronic LBP but remain underutilized.

Pharmacologic Therapy

First-Line

NSAIDs, such as naproxen 250 to 500 mg twice daily or ibuprofen 400 to 600 mg three times daily, are the most effective medication for acute LBP and should be used at the lowest effective dose for the shortest duration, with attention to gastrointestinal, renal, and cardiovascular risk. Topical NSAIDs such as diclofenac gel have fewer systemic side effects, though evidence specifically for LBP is limited.

Second-Line

Muscle relaxants such as cyclobenzaprine 5 to 10 mg at bedtime are useful for acute LBP only and for short-term use of less than 2 weeks; tizanidine and baclofen are alternatives, but all should be avoided in elderly patients due to sedation and fall risk. Duloxetine 60 mg daily is FDA-approved for chronic musculoskeletal pain including LBP and provides modest benefit while also treating comorbid depression and anxiety. Tricyclic antidepressants such as amitriptyline 10 to 75 mg at bedtime are used off-label for chronic LBP with limited evidence, and anticholinergic side effects limit their use in elderly patients.

Limited/No Role

Acetaminophen is not effective for LBP per multiple trials and is no longer recommended as first-line. Oral corticosteroids are not recommended, as systematic reviews show no benefit for radiculopathy or non-specific LBP. Gabapentin and pregabalin are not effective for sciatica or non-specific LBP per NICE guidelines and recent trials, though they may have a role in true neuropathic pain. Benzodiazepines should be avoided due to risk of dependence, sedation, and falls, with no proven benefit over muscle relaxants.

Opioids

Opioids are a last resort for chronic LBP when other therapies have failed. The CDC 2022 Clinical Practice Guideline states that opioids are not first-line and, if used, should be combined with non-pharmacologic therapy. Treatment should start with immediate-release opioids at the lowest effective dose, with clear goals, expectations, and functional outcomes established. The Opioid Risk Tool or SOAPP-R should be used for risk stratification before prescribing, and monitoring should include prescription drug monitoring programs (PDMP) and periodic urine drug testing. Long-term opioid therapy shows poor outcomes for chronic LBP, with no evidence of sustained benefit and significant risks. Forced rapid tapers should be avoided in favor of an individualized approach.

Interventional Procedures

Epidural Steroid Injections (ESI)

Epidural steroid injections are indicated for radiculopathy refractory to 4 to 6 weeks of conservative treatment. Approaches include interlaminar, transforaminal (more targeted and preferred for unilateral radiculopathy), and caudal. They provide short-term pain relief lasting weeks to months to facilitate participation in physical therapy, but there is no evidence of long-term benefit or prevention of surgery. Injections should be limited to 3 to 4 per year with fluoroscopic guidance recommended.

Facet Joint Interventions

Facet-mediated pain presents as axial LBP worsened by extension and rotation without radicular symptoms. Diagnostic medial branch blocks confirm the facet joint as the pain source. Radiofrequency ablation (neurotomy) provides longer-lasting relief if diagnostic blocks are positive, with relief typically lasting 6 to 12 months.

Sacroiliac Joint Interventions

SI joint pain presents as buttock pain that may radiate to the posterior thigh, with positive provocative tests including FABER, compression, distraction, and thigh thrust. Diagnostic SI joint injection performed with fluoroscopic or ultrasound guidance confirms the diagnosis. Radiofrequency ablation is used for confirmed SI joint pain.

Trigger Point Injections

Trigger point injections are indicated for myofascial pain with identifiable trigger points. They are performed using lidocaine or dry needling, though evidence is modest.

Spinal Cord Stimulation

Spinal cord stimulation is appropriate for chronic radicular pain refractory to other treatments. A trial period precedes permanent implant placement. Evidence supports its use for failed back surgery syndrome and complex regional pain syndrome. Referral to a pain management specialist is required.

Surgical Indications

Cauda equina syndrome, presenting with urinary retention, saddle anesthesia, and bilateral leg weakness, is a surgical emergency. Progressive motor deficit despite conservative treatment is another indication. Severe radiculopathy not responding to 6 to 12 weeks of conservative treatment plus epidural steroid injection, and spinal stenosis with neurogenic claudication significantly limiting function despite conservative management, are also considered surgical indications. Common procedures include microdiscectomy for disc herniation, laminectomy for stenosis, and spinal fusion for instability or spondylolisthesis. Shared decision-making is essential, as outcomes of surgery versus conservative treatment converge at 1 to 2 years for most conditions, with the exception of cauda equina syndrome.

Lumbar Spinal Stenosis

Lumbar spinal stenosis involves narrowing of the spinal canal causing neurogenic claudication. The classic symptom is bilateral leg pain or heaviness with walking or standing that is relieved by sitting or leaning forward (the shopping cart sign). It must be differentiated from vascular claudication: neurogenic claudication improves with flexion and sitting, while vascular claudication improves with standing still. Management includes physical therapy with flexion-based exercises and cycling, NSAIDs, and epidural injections for symptom management, with surgical decompression reserved for severe and refractory cases.

Chronic Pain Framework

The management of chronic pain requires a shift from the biomedical to the biopsychosocial model. Pain neuroscience education should explain central sensitization, neuroplasticity, and the difference between pain and tissue damage. Realistic goals should focus on function over pain elimination. Self-management strategies include pacing, flare planning, and valued-based activity engagement. Sleep, mood, and physical deconditioning should be addressed simultaneously. Iatrogenic harm from unnecessary imaging, repeated injections, long-term opioids, and surgical cascades must be avoided.

<image>A risk stratification tool for low back pain showing the STarT Back Screening Tool categories (low, medium, high risk for chronicity), the corresponding treatment pathways (minimal intervention for low risk, physical therapy for medium risk, combined physical and psychological treatment for high risk), and the yellow flag psychosocial factors that predict chronic pain development.</image>

<image>A treatment algorithm for chronic low back pain showing the multimodal approach starting with education and self-management, progressing through first-line therapies (exercise, PT, CBT), second-line options (duloxetine, multidisciplinary rehab, acupuncture), interventional procedures (ESI, facet blocks, RFA), and surgical considerations, with criteria for advancing through each level.</image>

<image>An anatomical diagram showing the three main pain generators in the lumbar spine (disc, facet joint, sacroiliac joint) with their characteristic pain patterns, physical exam findings, and the corresponding interventional procedures for each: epidural steroid injection for discogenic/radicular pain, medial branch block and radiofrequency ablation for facet pain, and SI joint injection for sacroiliac dysfunction.</image>

Clinical Pearls

Imaging findings in LBP often do not correlate with symptoms; disc bulges and degenerative changes are common in asymptomatic individuals and should not be overinterpreted. Psychosocial yellow flags such as catastrophizing, fear-avoidance, depression, and workplace issues are stronger predictors of chronic pain development than any imaging finding. Acetaminophen is not effective for low back pain and is no longer recommended as a first-line analgesic for this condition. The STarT Back tool is a validated method to match treatment intensity to patient risk: low-risk patients do well with reassurance and self-management, while high-risk patients need combined physical and psychological treatment. Oral corticosteroids do not improve outcomes in acute LBP or radiculopathy and should not be prescribed. Early return to activity and work with modifications if needed produces better outcomes than prolonged rest or activity avoidance. Epidural steroid injections provide short-term relief for radiculopathy but do not change long-term outcomes or prevent surgery; they should be used to facilitate rehabilitation. Long-term opioid therapy for chronic LBP shows no evidence of sustained benefit and carries significant risks of dependence, hyperalgesia, and functional decline; all other options should be exhausted first.

References

• Qaseem A et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: ACP Clinical Practice Guideline. Ann Intern Med. 2017
• Foster NE et al. Stratified Care vs. Best Current Practice (STarT Back). Lancet. 2011
• Dowell D et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain. MMWR. 2022
• Chou R et al. Systemic Pharmacological Therapies for Low Back Pain: ACP/APS Guideline. Ann Intern Med. 2017
• Machado GC et al. Efficacy of Paracetamol for Acute Low Back Pain (PACE Trial). Lancet. 2014

Read this lecture as Markdown